AGO2 and breast carcinoma: Interestingly, the overexpression of AGO2 in MCF-7 human breast cancer cells increased the expression of an ERα variant called ERα36, and stimulated E2-induced xenograft tumor growth in vivo in severe combined immunodeficiency (SCID)/Beige female mice [100].